Home » All » Stock Forecast » Climb Bio Inc. Common Stock Forecast

Climb Bio Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +4.46%Market Cap $447.59M · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$9.51 ▲ +1.50%	Yesterday	$9.31 ▼ -0.63%	Tomorrow's Climb Bio Inc. Common Stock (CLYM) setup is anchored to $9.37 and targets $9.51 (+1.50%). The near-term read is upside; watch $9.65 / $9.09 because daily realized volatility is about 7.75%.
Tomorrow's Climb Bio Inc. Common Stock (CLYM) setup is anchored to $9.37 and targets $9.51 (+1.50%). The near-term read is upside; watch $9.65 / $9.09 because daily realized volatility is about 7.75%.
Week	$9.81 ▲ +4.67%	Last Week	$9.19 ▼ -1.96%	The 7-day Climb Bio Inc. Common Stock model moves from $9.19 to $9.81 (+4.67%). It gives upside momentum context for this stock, so breaks around $9.65 / $9.09 matter more than a single tick.
The 7-day Climb Bio Inc. Common Stock model moves from $9.19 to $9.81 (+4.67%). It gives upside momentum context for this stock, so breaks around $9.65 / $9.09 matter more than a single tick.
Month	$10.30 ▲ +9.96%	Last Month	$8.98 ▼ -4.18%	The 1-month Climb Bio Inc. Common Stock target is $10.30 (+9.96%), compared with the live reference near $9.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Climb Bio Inc. Common Stock target is $10.30 (+9.96%), compared with the live reference near $9.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$11.04 ▲ +17.87%	Last Year	$8.67 ▼ -7.51%	The 1-year Climb Bio Inc. Common Stock scenario points to $11.04 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Climb Bio Inc. Common Stock scenario points to $11.04 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$12.78 ▲ +36.43%	5 Years Ago	$7.94 ▼ -15.30%	The 5-year Climb Bio Inc. Common Stock view is $12.78 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Climb Bio Inc. Common Stock view is $12.78 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$9.51▲ +1.50%

Yesterday$9.31▼ -0.63%

Tomorrow's Climb Bio Inc. Common Stock (CLYM) setup is anchored to $9.37 and targets $9.51 (+1.50%). The near-term read is upside; watch $9.65 / $9.09 because daily realized volatility is about 7.75%.

Week$9.81▲ +4.67%

Last Week$9.19▼ -1.96%

The 7-day Climb Bio Inc. Common Stock model moves from $9.19 to $9.81 (+4.67%). It gives upside momentum context for this stock, so breaks around $9.65 / $9.09 matter more than a single tick.

Month$10.30▲ +9.96%

Last Month$8.98▼ -4.18%

The 1-month Climb Bio Inc. Common Stock target is $10.30 (+9.96%), compared with the live reference near $9.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$11.04▲ +17.87%

Last Year$8.67▼ -7.51%

The 1-year Climb Bio Inc. Common Stock scenario points to $11.04 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$12.78▲ +36.43%

5 Years Ago$7.94▼ -15.30%

The 5-year Climb Bio Inc. Common Stock view is $12.78 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$9.37	Mid
Daily Change	+4.46%	Above
Volatility Cap	20.0%	Mid
Confidence	67%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$9.37

Daily Change+4.46%

Market Cap$447.59M

Sourcenasdaq-screener

Current	$9.37	Daily Change	+4.46%
Market Cap	$447.59M	Source	nasdaq-screener

Support & Resistance Levels

$9.09Support 1

$9.37Current

$9.65Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$9.37Live reference price

Used as the anchor for generated forecast calculations.

Next Month$10.30Model projection+9.96%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

67%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

67%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CLYM today

Bullish Scenario

$9.84

+5.00% from current

Target Price$9.84

ScenarioUpside momentum

Probability59%

Base Scenario

$10.30

+9.96%

Target Price$10.30

ScenarioCapped drift

Probability67%

Bearish Scenario

$8.90

-5.00% from current

Target Price$8.90

ScenarioVolatility drawdown

Probability33%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 71/100

24H drift+1.50%

7D drift+4.67%

30D drift+9.96%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 68/100

1M outlook+9.96%

1Y outlook+17.87%

5Y outlook+36.43%

Frequently Asked Questions

Q What is the Climb Bio Inc. Common Stock (CLYM) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Climb Bio Inc. Common Stock is projected near $9.51 versus the current reference around $9.37. That implies a modeled move of +1.50% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CLYM?

The weekly Climb Bio Inc. Common Stock model points to $9.81, which maps to an expected drift of +4.67% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Climb Bio Inc. Common Stock 1-month and 1-year targets?

The Climb Bio Inc. Common Stock 1-month target is $10.30 (+9.96%), while the 1-year target is $11.04 (+17.87%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Climb Bio Inc. Common Stock 5-year scenario differ from short-term rows?

The Climb Bio Inc. Common Stock long-horizon scenario sits near $12.78 with a modeled change of +36.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CLYM support and resistance zones right now?

For Climb Bio Inc. Common Stock, nearest resistance is around $9.09, while nearest support is around $9.65. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Climb Bio Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.